A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

NCT02855125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: TAS-114
DRUG: S-1

Sponsor

Taiho Oncology, Inc.